This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sellman, B. R.
Right arrow Articles by Baker, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sellman, B. R.
Right arrow Articles by Baker, S. M.

 Previous Article  |  Next Article 

Infection and Immunity, July 2008, p. 2950-2957, Vol. 76, No. 7
0019-9567/08/$08.00+0     doi:10.1128/IAI.00055-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Expression of Staphylococcus epidermidis SdrG Increases following Exposure to an In Vivo Environment{triangledown}

Bret R. Sellman,{dagger} Yekaterina Timofeyeva,* Jasdeep Nanra, Adrienne Scott, James P. Fulginiti, Yury V. Matsuka, and Steve M. Baker

Wyeth Vaccine Research, Pearl River, New York

Received 15 January 2008/ Returned for modification 15 February 2008/ Accepted 31 March 2008

SdrG is a surface-associated fibrinogen binding protein present in most strains of Staphylococcus epidermidis. Surface expression of SdrG was not detected by flow cytometry or immunofluorescence microscopy on S. epidermidis 0-47 grown in nutrient broth or in the presence of human serum. sdrG transcript levels increased 1 hour following a shift from growth in nutrient broth to growth in the bloodstream of a mouse and resulted in a concomitant increase in protein levels as detected by immunofluorescence microscopy. The environmental signal(s) resulting in the increase in expression is elusive, as growth under conditions known to mimic in vivo conditions (elevated CO2, iron limitation, human serum, and citrated human blood) did not affect expression of SdrG. Immunizing mice with either the N1N2N3 (amino acids 50 to 597) or N2N3 (amino acids 273 to 597) subdomain of the N-terminal A domain of recombinant SdrG (rSdrG) elicited a robust antibody response; however, only mice vaccinated with rSdrGN23 exhibited a significant reduction in 0-47 recovered after experimental infection. Since SdrG is expressed early during infection in response to specific host environmental cues present in the bloodstream and since antibodies to it are effective in reducing bacteremia, SdrG possesses attributes of a vaccine component effective against the pathogenic form of the ubiquitous human commensal S. epidermidis.

* Corresponding author. Mailing address: Wyeth Vaccine Research, 401 N. Middletown Rd., Pearl River, NY 10965. Phone: (845) 602-8685. Fax: (845) 602-4350. E-mail: timofey{at}wyeth.com

{triangledown} Published ahead of print on 21 April 2008.

Editor: R. P. Morrison

{dagger} Present address: Medimmune, Inc., Dept. of Infectious Diseases, 1 Medimmune Way, Gaithersburg, MD 20878.

Infection and Immunity, July 2008, p. 2950-2957, Vol. 76, No. 7
0019-9567/08/$08.00+0     doi:10.1128/IAI.00055-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»